Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition

Overview of attention for article published in Frontiers in Medicine, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 27,770 followers.

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition - PMC …. $RVT https://t.co/j98laDU5wN

RT @RheumNow: Comprehensive, full-read overview of SLE treatment with Tyk2 vs JAK inhibitors https://t.co/KjLEYGfxAY https://t.co/btvoBQjb…

RT @RheumNow: Comprehensive, full-read overview of SLE treatment with Tyk2 vs JAK inhibitors https://t.co/KjLEYGfxAY https://t.co/btvoBQjb…

RT @RheumNow: Comprehensive, full-read overview of SLE treatment with Tyk2 vs JAK inhibitors https://t.co/KjLEYGfxAY https://t.co/btvoBQjb…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.